IPO registrations (S-1, F-1) · Registrants

DermTech, Inc.

SEC CIK
1651944 · filings on EDGAR ↗
Former names
Constellation Alpha Capital Corp. (2015–2019)
Registration
Form S-1, first filed 2017-05-18, last 2020-05-04; 3 initial registrations, 3 amendments
Outcome
Final prospectus filed 2017-06-21; declared effective 2017-06-19; withdrawal requested 2019-09-25
Industry (SIC)
Services-Medical Laboratories 8071
Incorporated in
DE
Business address
12340 EL CAMINO REAL, San Diego, CA 92130
EIN
84-2870849
EDGAR entity type
operating
Insiders and CEO pay
DermTech, Inc. on the corporate pages

Offering terms

Final price
$10.00 per share (424B4 filed 2017-06-21, an initial public offering)
Shares sold
12,500,000
Gross proceeds
$125,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CNAC
Lead underwriters
Cowen
Syndicate
Chardan; I-Bankers Securities, Inc

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 17

FiledFormWhat it isName as filedEDGAR
2017-05-18S-1S-1 (registration)Constellation Alpha Capital Corp.0001144204-17-028458 ↗
2017-06-09S-1/AS-1/A (amendment)Constellation Alpha Capital Corp.0001144204-17-031908 ↗
2017-06-14S-1/AS-1/A (amendment)Constellation Alpha Capital Corp.0001144204-17-032588 ↗
2017-06-19EFFECTEFFECT (declared effective)Constellation Alpha Capital Corp.9999999995-17-001582 ↗
2017-06-21424B4424B4 (final prospectus)Constellation Alpha Capital Corp.0001144204-17-033374 ↗
2019-08-07EFFECTEFFECT (declared effective)Constellation Alpha Capital Corp.9999999995-19-001826 ↗
2019-09-25RWRW (withdrawal request)DermTech, Inc.0001193125-19-254808 ↗
2019-11-14RWRW (withdrawal request)DermTech, Inc.0001193125-19-291312 ↗
2020-01-03S-1S-1 (registration)DermTech, Inc.0001193125-20-000753 ↗
2020-02-06S-1/AS-1/A (amendment)DermTech, Inc.0001193125-20-026831 ↗
2020-02-10EFFECTEFFECT (declared effective)DermTech, Inc.9999999995-20-000302 ↗
2020-05-04S-1S-1 (registration)DermTech, Inc.0001564590-20-020848 ↗
2020-05-11EFFECTEFFECT (declared effective)DermTech, Inc.9999999995-20-001120 ↗
2020-09-17EFFECTEFFECT (declared effective)DermTech, Inc.9999999995-20-002488 ↗
2020-09-17EFFECTEFFECT (declared effective)DermTech, Inc.9999999995-20-002489 ↗
2020-11-09EFFECTEFFECT (declared effective)DermTech, Inc.9999999995-20-003103 ↗
2020-11-09EFFECTEFFECT (declared effective)DermTech, Inc.9999999995-20-003104 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2017-06-14S-1/Aregistration statement$10.0012,500,000$125,000,000Nasdaq CNAC2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗
2017-06-21424B4final prospectus$10.0012,500,000$125,000,000Nasdaq CNAC3primary document; price sentence, shares headline, proceeds table, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Alexander John JosephDirector12017
Centripetal, LLCTenPercentOwner22017
Handa KewalDirector12017
Pollak CraigOfficerCFO and Secretary12017
Rosling AlanDirector12017
Shukla RajivDirector,Officer,TenPercentOwnerCEO and Chairman; CEO & Chairman22017
Polar Asset Management Partners Inc.TenPercentOwner22018–2019
COWEN AND COMPANY, LLCTenPercentOwner22019
Cowen Holdings, Inc.TenPercentOwner22019
COWEN INC.TenPercentOwner22019
Cowen Investments II LLCTenPercentOwner22019
RCG LV Pearl LLCTenPercentOwner22019
SOLOMON JEFFREY MTenPercentOwner22019
Collins CynthiaDirector72019–2023
Dobak JohnDirector,OfficerChief Executive Officer292019–2023
Irwin & Joan Jacobs Trust Dated 6-2-80TenPercentOwner32019–2020
Jacobs Gary E.Director; Director,TenPercentOwner72019–2021
JACOBS IRWIN MTenPercentOwner32019–2020
Jansen BurkhardOfficerChief Medical Officer82019–2021
Kemper Steven JOfficerChief Financial Officer12019
PANCOAST SCOTT RDirector112019–2021
Picozza EnricoDirector82019–2021
Posard Matthew L.Director92019–2023
ROSENMAN HERMDirector92019–2023
RTW INVESTMENTS, LPTenPercentOwner82019–2022
Salkind GeneDirector32019–2020
WONG RODERICKTenPercentOwner82019–2022
Wood Todd MichaelOfficerChief Commercial Officer; Chief Commerical Officer292019–2023
Yao ZuxuOfficerChief Scientific Officer42019–2020
Sun Kevin MOfficerCFO; Chief Financial Officer252019–2024
Jacobs JoanTenPercentOwner22019–2020
Ibarra ClaudiaOfficerChief Operating Officer272020–2023
Akhavan RaminOfficerGeneral Counsel122021–2024
Tellado MonicaDirector32021–2022
Keraudy Nathalie GerschteinDirector42021–2023
Capone Mark ChristopherDirector32022–2023
Malloy KirkDirector32022–2023
Christensen BretDirector,OfficerChief Executive Officer22023
Aguillard Mark BryanOfficerChief Commercial Officer22023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2020-03-16DermTech, Inc.Other Health Care$64,999,991$64,999,991251
2020-02-19DermTech, Inc.Other Health Care$181,975$181,97561

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerDermTech, Inc.CAForm D private offeringsCIK (EXACT)
Patent assigneeDERMTECH, LLCCAPatents (USPTO)name and state
SEC filerDermTech, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerDermTech, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorDERMTECHEIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.